I think the FDA's normal process is extremely flawed and would like to see more expedited trails that allow early-opt-in and continually expanding test groups that ramp up in size as efficacy and safety is proven.
It's criminal that the FDA has effectively sat on mRNA tech for decades while watching people who could have benefit from it die. The FDA deemed mRNA tech unsafe to give to much smaller groups of people already directly affected with various mRNA treatable diseases yet now after a few months of testing they have amazingly deemed it safe to give to to the entire world. The risk calculus just isn't consistent.
The way you worded your proceeding comment made it sound as if you would have preferred the FDA to not approve the Covid mRNA vaccines, as opposed to preferring easier approvals for other mRNA tech in general.
To extend my quip, the people who could benefit from it each have their own little fire and are being systematically ignored.
Clinical trials take long because they are evaluating long term side effects. They didn't deem it unsafe to give to smaller groups of people, in many cases the company withdrew it from consideration because earlier uses were centered on oncology - taking pieces of patients' cancer cells and attempting to get the body to fight them immunologically - and they weren't able to obtain a clinically significant impact. Running a long term clinical trial is an expensive proposition.
It's criminal that the FDA has effectively sat on mRNA tech for decades while watching people who could have benefit from it die. The FDA deemed mRNA tech unsafe to give to much smaller groups of people already directly affected with various mRNA treatable diseases yet now after a few months of testing they have amazingly deemed it safe to give to to the entire world. The risk calculus just isn't consistent.